Monoallelic ABCA4 Mutations Appear Insufficient to Cause Retinopathy: A Quantitative Autofluorescence Study
2015
PURPOSE: To investigate the effect of
ABCA4mutation status on
lipofuscin-related quantitative
autofluorescence(qAF) in humans and on bisretinoid accumulation in mice. METHODS: Genotyped parents (n = 26; age 37-64 years) of patients with biallelic
ABCA4-related retinopathy underwent in-depth retinal phenotyping including qAF imaging as a surrogate measure for RPE
lipofuscinaccumulation. In addition, bisretinoids as the main components of
autofluorescent
lipofuscinat the ocular fundus were quantified in
Abca4-/-,
Abca4+/-, and wild-type mice. RESULTS: Index patients showed a retinal phenotype characteristic for
ABCA4-related retinopathy, including increased qAF levels. In contrast, qAF measures in carriers of only one
ABCA4mutation were not different from age-matched controls in this sample, and there was no difference between truncating and missense mutations. Also, none of these carriers presented an abnormal phenotype on conventional imaging. One parent with
ABCA4-related retinopathy and increased qAF carried an additional
ABCA4mutation, explaining the phenotype under a recessive disease model (
pseudodominance). Biochemical analysis in the mouse model revealed direct downstream products (A2PE-H2, at-RALdimer-PE) of the
ABCA4substrate N-Ret-PE to be similar in wild-type and
Abca4+/- mice. Both bisretinoids were 12- to 18-fold increased in
Abca4-/- mice. Levels of A2E and A2PE in
Abca4+/- mice were in between those measured in wild-type and
Abca4-/- mice. CONCLUSIONS: This study indicates that carriers of monoallelic
ABCA4mutations are phenotypically normal. However, biochemical analysis in the
Abca4-deficient mouse model suggests detectable effects of one mutation in
ABCA4on the molecular level. The findings may have implications for therapeutic approaches such as gene replacement therapy.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
42
References
32
Citations
NaN
KQI